ClinicalTrials.gg
RecruitingNCT06675227EBSBP-01Updated Oct 6, 2026

Comparison of Electrolyte Beverages and Water as Solvents for Bowel Preparation

An interventional study of electrolyte beverages in Bowel Preparation Before Colonoscopy, sponsored by Third Military Medical University. Recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by Third Military Medical University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.
Updated Oct 6, 2026Primary completion movedStudy completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2,766
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Using Electrolyte Beverages as replacement for water to dissolve PEG(2L plan) in bowel preparation process.

The aim of this study is to test whether Electrolyte Beverages as solvents can improve the cleanness of bowel preparation and the satisfaction of patients.

Read the detailed description

The application of electronic colonoscopy has shown a significant upward trend in the diagnosis, screening, and health check-ups for colorectal diseases.

To clean the colon, patients must consume several liters of bowel preparation solution in a short period before the procedure.

However, a significant number of patients experience nausea or even vomiting, preventing them from completing the recommended dose, resulting in suboptimal bowel preparation and affecting the colonoscopy process.

Therefore, the investigators have designed a protocol that uses sugar-free electrolyte beverages instead of regular drinking water as a solvent for the laxative solution. By improving the taste of the oral solution and increasing the electrolyte content, the investigators aim to enhance patient compliance with colonoscopy preparation and ultimately assess the effectiveness of bowel cleansing.

02

Conditions studied

  • Bowel Preparation Before Colonoscopy

Keywords

  • bowel preparation
  • Electrolyte Beverages
03

In context

Lead sponsor

Third Military Medical University is the lead sponsor of 84 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Healthy individuals or those with mild or well-controlled chronic diseases.
  2. Patients scheduled for outpatient colonoscopy.
  3. Patients prescribed sodium phosphate or polyethylene glycol for bowel preparation.
  4. Willing to participate and sign the form.
  5. Age ≥18 years
  6. performance status \<2

Exclusion criteria

Exclusion Criteria:

  1. Patients who refuse to participate in the study.
  2. Patients requiring enema preparation.
  3. Uncontrolled hypertension.
  4. Patients with diabetes.
  5. Pregnant patients.
  6. Suspected bowel obstruction.
  7. Risk of aspiration.
  8. Patients with severe ulcerative colitis, gastric retention, bowel perforation, toxic colitis, or megacolon.
  9. Patients with severe systemic diseases (including class 3-4 heart failure, class C liver failure).
  10. Patients with a known allergy to polyethylene glycol.
  11. Patients with a history of major gastrointestinal surgery or any other conditions that may interfere with study outcomes or adherence.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ECOG performance status

A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.

0
Fully active, no restrictions.
1
Limited in strenuous activity, but walking and able to do light work, such as housework or office work.
2
Walking and able to look after yourself, but unable to work; up and about more than half of waking hours.
3
Able to look after yourself only in part; in bed or a chair more than half of waking hours.
4
Unable to look after yourself at all; in bed or a chair all day.

Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

Child-Pugh class

A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Investigator)
Enrollment
2,766 participants (estimated)

Study arms

  • No intervention
    Drinking Water Group

    This group will apply the ordinary drinking water as the solvents for 2L PEG to dissolve.

  • Experimental
    Electrolyte Beverages Group

    This group will apply the electrolyte beverages(Alienergy) instead of ordinary drinking water as the solvents for 2L PEG to dissolve.

    Dietary Supplement: electrolyte beverages

Interventions

  • Dietary supplementelectrolyte beverages

    Using Electrolyte Beverages as replacement for water to dissolve PEG(2L plan) in bowel preparation process.

06

What researchers measure

Primary outcomes

  1. The Boston Bowel Preparation Scale

    The BBPS is a standardized 9-point assessment scale for the colon. The structure of the colon is divided into its three segments: right colon, transverse colon, and left colon. Each segment is classified from 0 to 3 depending on the degree of soiling. The sum total of the three segments represents the degree of soiling, so that a total ≤ 5 points shows poor bowel preparation, while 6-7 shows good bowel preparation, and ≥ 8 very good bowel preparation.

    Time frame: From enrollment to the time point when patients finished colonscopy (within a week).

Secondary outcomes

  1. The Palatability

    The palatability of different bowel preparation regimens will be assessed using a 4-point scale. The scoring system is as follows: 1 = very poor, 2 = poor, 3 = good, 4 = very good. Each participant's score will be collected and statistically analyzed.

    Time frame: From enrollment to the time point when patients finished colonscopy(within a week).

  2. Lesion Detection Rate

    The proportion of polyps, tumors, inflammatory bowel disease, and diverticulosis detected during colonoscopy under different bowel preparation regimens will be recorded. The detection rate will be expressed as a percentage, and differences between the groups will be analyzed.

    Time frame: From enrollment to the time point when patients finished colonscopy (within a week).

Other outcomes

  1. Patient Willingness to Repeat

    The willingness of patients to undergo a repeat colonoscopy after the procedure will be recorded and analyzed. This will be quantified using a Yes/No format, and the proportion of willingness in each group will be calculated.

    Time frame: From enrollment to the time point before colonscopy(within a week).

  2. Bowel Preparation Time

    The total time (in minutes) required for each patient to complete 2000 ml of bowel preparation solution will be recorded, and the average time and standard deviation will be calculated.

    Time frame: From enrollment to the time point before colonscopy(within a week).

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Nov 2024 (actual). Primary completion is estimated for Jun 2027, 31 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: primary completion Dec 2025 → Jun 2027 and completion Dec 2025 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2024
First posted
Nov 5, 2024
StartActual
Nov 11, 2024
Primary completionEst.
Jun 30, 2027was Dec 2025
CompletionEst.
Dec 31, 2027was Dec 2025
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • Army Medical Center · Chongqing, China
Show 1 removed
  • Army Medical Center · Chongqing, China
Oct 6, 2026
Primary completion
Dec 30, 2025→Jun 30, 2027
Oct 6, 2026
Study completion
Dec 31, 2025→Dec 31, 2027
Oct 6, 2026
Sponsor
Collaborators added: People's Hospital of Chongqing; collaborators removed: Fuling people's hospital of Chongqing
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    1 site added, 1 site removed
    Show site
    • Army Medical Center · Chongqing, China
    Show 1 removed
    • Army Medical Center · Chongqing, China
    Primary completion Dec 30, 2025→Jun 30, 2027
    Study completion Dec 31, 2025→Dec 31, 2027
    Sponsor Collaborators added: People's Hospital of Chongqing; collaborators removed: Fuling people's hospital of Chongqing
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06675227
Lead sponsor
Third Military Medical University
Collaborators
The thirteenth people's hospital of Chonqing, People's Hospital of Chongqing
Responsible party
Weidong Tong (Director, Third Military Medical University) — Principal investigator
First posted
Nov 5, 2024
Start date
Nov 11, 2024
Primary completion
Jun 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 6, 2026

Study contacts

Kun Xv
Contact
vdtong@163.com
13500321218
Weidong Tong, MD
principal investigator · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion